Not applicableStudy completedNCT01502020
What this trial is testing
A Bioequivalence Study With Clinical Endpoints Comparing Generic Imiquimod Cream, 3.75% and Zyclara™ (Imiquimod) Cream, 3.75% in Subjects With Actinic Keratoses
Who this might be right for
Actinic Keratoses
Actavis Mid-Atlantic LLC 410